16 Dec. 2020
This document provides guidance to Ministries of Health (MOHs), laboratory personnel and implementing partners in African Union Member States on the application of rapid antigen tests to COVID-19 testing. The guidance serves as reference for policymakers, laboratory leads, implementing... partners, and experts on use case scenarios and associated testing algorithms for COVID-19 antigen tests. It recommends the use of antigen tests to increase access to testing and enable timely results for persons with or without symptoms in specific settings. The document will be reviewed and updated as more evidence becomes available regarding the use of rapid antigen tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from global studies and evaluation efforts.
more
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac...y of the most promising vaccine candidates among the region’s populations.
While current COVID-19 clinical trial activity on the continent is limited, Africa has substantial experience and capabilities to conduct clinical trials for preventative vaccines across a range of diseases, and many organizations on the continent are working tirelessly to help prepare additional trials on potential COVID-19 vaccines. As the number of candidate vaccines in the development pipeline continues to increase, it will be important for organizations responsible for managing clinical trials in the region to partner with vaccine developers to identify potential and appropriate trial locations, provide support to remove any critical obstacles impeding commencement and progress of trials, and to provide oversight ensuring that trials are conducted safely and ethically.
more
Compte tenu des lacunes en matière d'infrastructures et de ressources, il convient d'envisager de recourir à la technologie pour la gestion à distance des soins de santé dispensés aux patients pendant cette période. Comme on peut le constater, même les pays disposant d'infrastructures et de r...essources de soins de santé plus avancées ont eu du mal à traiter les patients atteints de COVID-19 ou non pendant cette pandémie.
more
The virtual conference, co-organised by the Africa Centres for Disease Control and Prevention (Africa CDC) and the South African Medical Research Council (SAMRC) brought together African leaders, public health professionals and researchers, policymakers, business leaders and civil society and commun...ity leaders.
The objective was to discuss strategies and approaches to remove barriers to widespread delivery and uptake of effective COVID-19 vaccines across Africa, guided by African voices and indigenous values. The goal of the conference was to provide input for a framework for fair, equitable and timely allocation of COVID-19 vaccines in Africa.
more
Mars 2020. Recommendations selon les differentes phases
Mars 2020. Recommendations selon les differentes phases
The twentieth century ended with human African trypanosomiasis (HAT) epidemics raging across many parts of Africa. Resistance to existing drugs was emerging, and many programs aiming to contain the disease had ground to a halt, given previous success against HAT and the competing priorities associat...ed with other medical crises ravaging the continent. A series of dedicated interventions and the introduction of innovative routes to develop drugs, involving Product Development Partnerships, has led to a dramatic turnaround in the fight against HAT caused by Trypanosoma brucei gambiense. The World Health Organization have been able to optimize the use of existing tools to monitor and intervene in the disease. A promising new oral medication for stage 1 HAT, pafuramidine maleate, ultimately failed due to unforeseen toxicity issues. However, the clinical trials for this compound demonstrated the possibility of conducting such trials in the resource-poor settings of rural Africa.
more
Cholera is an acute diarrhoeal infection caused by ingestion of contaminated water or food. This course provides a general introduction to cholera and is intended for personnel responding to outbreaks in complex emergencies or in settings where the basic environmental infrastructures have been damag...ed or destroyed. It includes materials that can be accessed in English, Arabic and Hausa.
Free Online Course. Learning objectives: By the end of this course, participants should be able to: describe the case definition and alerts for cholera; describe main transmission routes; list list the key preventive actions; and explain how cholera control is multisectoral.
Course duration: Approximately 1 hour.
more
The Strong Families Programme was developed and piloted in Afghanistan thanks to the generous support of the US-INL. To date, this programme has further been piloted in Central America, Central and West Asia, East and West Africa thanks to the support of Sweden, France and the US
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
N Engl J Med 2019;380:2429-39.DOI: 10.1056/NEJMoa1901113
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are ...contributing to the (re)emergence of infectious diseases such as population growth, living in close contact with animals, frequent travelling, poverty, destructive ecological changes due to economic development and land use and climate change result in global warming.
Especially Africa is at a threat for (re)emerging infectious diseases due to the huge population growth (expected to reach 2.5 billion by 2050) with rapid urbanisation. Additionally, people across and beyond the continent are excessively mobile which is combined with a weak health system. Moreover, the risk of (re)emerging infectious disease is further heightened by three newly adopted continental initiatives: African Continental Free Trade Area, Free Movement of Persons and African Passport and Single African Air Transport Market.
more
The Lab identifies, develops, and launches sustainable finance
instruments that can drive billions to a low-carbon economy. The
2019 Global Lab Cycle targets four specific sectors across
mitigation and adaptation: blue carbon in marine & coastal
ecosystems; sustainable agriculture for smallholde...rs in West and
Central Africa; sustainable energy access; and sustainable cities
more
الكوليرا هي عدوى إسهالية حادة تنتج عن تناول طعام أو ماء ملوث. توفر هذه الدورة مقدمة عامة عن الكوليرا وتستهدف الأفراد المسئولين عن الاستجابة لفاشيات المرض في حالات ا...طوارئ المعقدة أو في البيئات التي تعرضت فيها البنية التحتية البيئية الأساسية للتلف أو الدمار.
more
A cólera é uma infeção diarreica aguda causada pela ingestão de água ou alimentos contaminados. Este curso providencia uma introdução geral à cólera e é dirigido aos profissionais que responde a surtos em emergências complexas ou em contextos onde as infraestruturas básicas ambientais f...oram danificadas ou destruídas.
more
This report is not a country scorecard. Rather, its purpose is to act as a compass to guide progress towards health in the SDGs.
There has been a significant improvement in the state of health in the region with healthy life expectancy - time spent in full health - in the region increasing from 50....9 years to 53.8 between 2012 and 2015 - the most marked increase of any region in the world.
What is making Africans sick is changing. The top killers are still lower respiratory infections, HIV and diarrhoeal disease and countries have routinely focused on preventing and treating this trio, often through specialized programmes. The payoff has been significant declines in deaths due to these diseases. There has been a 50% reduction in the burden of disease caused by what have been the top 10 killers since 2000 and death rates have dropped from 87.7 to 51.1 deaths per 100,000 persons between 2000 and 2015...
Chronic diseases like heart disease and cancer are now claiming more lives with a person aged 30 to 70 in the region having a one in five chance of dying from a noncommunicable disease (NCDs).
Countries are specifically failing to provide essential services to two critical age groups – adolescents and the elderly...
more
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...which meets annually to oversee smallpox research has highlighted the importance of diagnostics that could distinguish between variola and other strains of orthopoxviruses, including monkeypox virus. The ACVVR encourages the positive effects of current smallpox research on all orthopoxviruses, specifically monkeypox, such as the development of diagnostic tools.
more
C’est en agissant prestement sur le front économique que l’on a pu surmonter cette crise sanitaire
L’Afrique de l’Ouest et la communauté internationale ont dû faire face à une crise sanitaire sans précédent lorsqu’a éclaté, en mars 2014, la plus grande épidémie de la maladie... à virus Ébola jamais enregistrée. Celle-ci a fait plus de 11.000 morts et infecté plus de 28.000 personnes entre la fin 2013 et le début 2016.
L’importance des dépenses sanitaires et sociales que cette épidémie a exigées a aussi provoqué une crise économique, qui a été aggravée par l’effondrement presque concomitant des cours des produits de base. Déjà sous pression avant la survenue de l’épidémie, les systèmes sanitaires et sociaux de la Guinée, du Libéria et de la Sierra Leone — pays les plus touchés — ont été submergés.
more